[Results of questionnaires of 1670 dermatologists in West Germany concerning the side effects of griseofulvin therapy].
D000022:Abortion, Spontaneous / Q000139:chemically induced; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury; D003085:Colic / Q000139:chemically induced; D003881:Dermatomycoses / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D005860:Germany, West; D006118:Griseofulvin / Q000009:adverse effects* / Q000627:therapeutic use; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D011247:Pregnancy; D012189:Retrospective Studies; D011795:Surveys and Questionnaires
D006118:Griseofulvin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Ergebnisse einer Fragebogenaktion bei 1670 Dermatologen der Bundesrepublik Deutschland über Nebenwirkungen bei der Griseofulvintherapie.